FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Quinoline topics
Isoquinolin
Praziquantel
Carbon Atoms
Crystallin
Quinoline Derivatives
Pharmaceutically Acceptable Salt
Alkyl Group
Cycloalkyl
Pharmaceutically Acceptable Salts
Immunodeficiency
Retrovirus
Viral Infection
Human Immunodeficiency Virus
Angiogenesis
Sulfonamide

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Quinoline patents



      
           
This page is updated frequently with new Quinoline-related patent applications. Subscribe to the Quinoline RSS feed to automatically get the update: related Quinoline RSS feeds. RSS updates for this page: Quinoline RSS RSS


Date/App# patent app List of recent Quinoline-related patents
03/05/15
20150065502
 Antibacterial quinoline derivatives patent thumbnailnew patent Antibacterial quinoline derivatives
A pharmaceutically acceptable salt thereof, a n-oxide form thereof or a solvate thereof. The claimed compounds are useful for the treatment of a bacterial infection.
03/05/15
20150065499
 3-aminothieno[3,2-c]quinoline derivatives, methods of preparation and uses patent thumbnailnew patent 3-aminothieno[3,2-c]quinoline derivatives, methods of preparation and uses
The present invention relates to compounds according to formula i: and salts thereof, wherein r1, r2, r3, r4, r5, r6, r7, x, and y are as defined herein. Methods for preparing compounds of formula i are also provided.
Temple University - Of The Commonwealth System Of Higher Education
03/05/15
20150065489
 Substituted quinolines and their use as medicaments patent thumbnailnew patent Substituted quinolines and their use as medicaments
R1 and r2 are defined herein, the processing of making and using the same.. .
02/26/15
20150057312
 Substituted quinolines as bruton's tyrosine kinases inhibitors patent thumbnailSubstituted quinolines as bruton's tyrosine kinases inhibitors
The present invention is directed to novel quinolines, their derivatives, pharmaceutically acceptable salts, solvates and hydrates thereof. The compounds and compositions of the present invention have protein kinases inhibitory activities and are useful for the treatment of protein kinases mediated diseases and conditions.
Hangzhouderenyucheng Biotechnology Ltd
02/26/15
20150057311
 Heterocyclic gsk-3 allosteric modulators patent thumbnailHeterocyclic gsk-3 allosteric modulators
The present invention relates to heterocyclic substituted quinoline derivatives as allosteric inhibitors of the glycogen synthase kinase-3 (gsk-3) enzyme. Therefore, these compounds are useful for the manufacturing of a medicament designed for the treatment and/or prevention of diseases wherein gsk-3 is involved, such as neurodegenerative diseases, inflammatory diseases, cancer, diabetes, and to promote various regenerative processes..
Consejo Superior De Investigaciones Cientificas (csic)
02/26/15
20150056137
 Caspase-triggered nano-aggregation probes and methods of use patent thumbnailCaspase-triggered nano-aggregation probes and methods of use
Provided is an activatable probe that undergoes intramolecular cyclization and subsequent aggregation in apoptotic tumor cells upon peptidase-initiated, and most advantageously caspase-3, activation. These caspase-sensitive nano-aggregation probes (c-snafs) are generally biocompatible, possess nir spectral properties or may serve as pet or mri imaging agents, and have a mechanism of target-mediated nanostructure self-assembly amenable to in vivo use.
The Board Of Trustees Of The Leland Stanford Junior University
02/19/15
20150051419
 Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium patent thumbnailIntermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium
The present invention relates to processes for the preparation of quinoline-3-carboxamide derivatives, such as sodium 5-chloro-3-(ethylphenylcarbamoyl)-1-methyl-2-oxo-1,2-dihydroquinolin-4-olate (laquinimod sodium). The present invention further relates to intermediates formed in such processes..
Mapi Pharma Ltd.
02/19/15
20150051244
 Antibacterial quinoline derivatives patent thumbnailAntibacterial quinoline derivatives
The claimed compounds are useful for the treatment of a bacterial infection. Also claimed is a composition comprising a pharmaceutically acceptable carrier and, as active ingredient, a therapeutically effective amount of the claimed compounds, the use of the claimed compounds or compositions for the manufacture of a medicament for the treatment of a bacterial infection and a process for preparing the claimed compounds..
02/19/15
20150050260
 Pyrroloquinoline quinone based compositions and uses patent thumbnailPyrroloquinoline quinone based compositions and uses
The present invention provides pharmaceutical and dietary compositions in which pyrroloquinoline quinone (pqq) and its derivatives are combined with other biologically active compounds to produce a synergistic beneficial effect beyond the effect produced by pqq or its derivatives alone. The present invention also provides methods for providing various beneficial effects which comprise administering these compositions to a mammalian subject..
4141 Holdings, Llc
02/12/15
20150044711
 Glucose dehydrogenase patent thumbnailGlucose dehydrogenase
A modified pyrroloquinoline quinone glucose dehydrogenase that exhibits a high selectivity for glucose is provided. A modified pyrroloquinoline quinone glucose dehydrogenase is disclosed in which the amino acid residue g at position 99 of a pyrroloquinoline quinone glucose dehydrogenase (pqqgdh) represented by seq id no: 1, or the amino acid residue g at position 100 of the pyrroloquinoline quinone glucose dehydrogenase (pqqgdh) represented by seq id no: 3, is substituted by the amino acid sequence tgzn (where z is sx, s, or n and x is any amino acid residue).
Arkray, Inc.
02/05/15
20150038714

Process for synthesis of chiral 3-substituted tetrahydroquinoline derivatives


The present invention relates to novel and concise process for the construction of chiral 3-substituted tetrahyroquinoline derivatives based on proline catalyzed asymmetric α-functionalization of aldehyde, followed by in situ reductive cyclization of nitro group under catalytic hydrogenation condition with high optical purities. Further the invention relates to conversion of derived chiral 3-substituted tetrahydroquinoline derivatives into therapeutic agents namely (−)-sumanirole (96% ee) and 1-[(s)-3-(di-methylamino)-3,4-dihydro-6,7-dimethoxy-quinolin-1(2h)-yl]propanone[(s)-903] (92% ee)..
Council Of Scientific & Industrial Research
02/05/15
20150038529

Crystalline forms of a prolyl hydroxylase inhibitor


The present disclosure relates to crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid, the process of preparing the forms, and pharmaceutical compositions and methods of use thereof.. .
Fibrogen, Inc.
02/05/15
20150038528

4 -hydroxy- isoquinoline compounds as hif hydroxylase inhibitors


The present invention relates to novel compounds of formula (i), and compositions capable of inhibiting phd1 enzyme activity selectively over other isoforms, for example, phd2 and/or phd3 enzymes. The invention also relates to compounds of formula (i) for use in disorders such as muscle degeneration, colitis, ibd, and certain ischemias..
Fibrogen, Inc.
02/05/15
20150038493

Compounds that trap alpha-oxoaldehydes and alpha-beta-unsaturated aldehydes, meta-compounds containing such compounds, and use of said compounds in treating illnesses related to the accumulation of ages and ales


The present invention relates to a series of molecules derived from 2,3-diaminopropionic acid (dap), comprising or not comprising an 8-hydroxyquinoline (8-hq) motif, and to the use of said molecules for trapping an alpha-oxoaldehyde resulting particularly from the degradation of the glucose or for trapping an alpha-beta-unsaturated aldehyde, resulting particularly from the oxidative degradation of fatty acids. These molecules can have a further application in the fields of cosmetics, food processing, and pharmaceuticals..
Pharmamens
02/05/15
20150037308

Pyrroloquinoline quinone alcohol adduct


Wherein r is an alkyl group, a hydroxyalkyl group, a dihydroxyalkyl group, or an alkoxyalkyl group.. .
01/29/15
20150031893

An h3 receptor antagonist for use in the treatment of alzheimer's disease


This disclosure relates to methods of using 2-(cyclohexylmethyl)-n-{2-[(2s)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide in a disease modifying therapy of alzheimer's disease, other tauopathies and related neurodegenerative diseases.. .
Sanofi
01/29/15
20150031888

Process for the preparation of pyrido[2,1-a] isoquinoline derivatives by catalytic asymmetric hydrogenation of an enamine


Wherein r2, r3, r4 and prot are as defined in the specification.. .
01/29/15
20150031723

Quinoline compounds which are anti-angiogenic integrin alpha5 beta1 inhibitors for use in the treatment of fibrosis or fibrosis-related diseases


A new medical therapy, and more particularly certain quinoline compounds which are anti-angiogenic integrin aplha5beta1 inhibitors, for use in the treatment of fibrosis, or a fibrosis-related disease, such as a fibrotic disease affecting the lung, liver, kidney, skin, epidermis, endodermis, muscle, tendon, cartilage, heart, stomach, large intestine, small intestine, colon, uterus, nervous system, testis, adrenal gland, artery, vein, biliary tract, or eye.. .
Clanotech Ab
01/29/15
20150031696

Cyanoisoquinoline compounds and methods of use thereof


The present invention relates to cyanoisoquinoline compounds suitable for use in treating hypoxia inducible factor-mediated and/or erythropoietin-associated conditions. The cyanoisoquinoline compounds of the invention have the following structure:.
Fibrogen, Inc.
01/29/15
20150031692

Substituted pyrano and furanoquinolines, their preparation and use as medicaments


The present invention relates to new substituted pyrano and furanoquinolines having a great affinity for sigma receptors, especially sigma-1 receptors, as well as to the process for the preparation thereof, to compositions comprising them, and to their use as medicaments.. .
Laboratorios Del Dr. Esteve S.a.
01/22/15
20150025108

8-hydroxy quinoline derivatives


Or pharmaceutically acceptable salts, hydrates, or solvates thereof.. .
01/22/15
20150025085

Iron chelators and uses thereof


8-hydroxy-quinoline derivatives and 8-ethers, 8-esters, 8-carbonates, 8-acyloxymethyl, 8-phosphates, 8(phosphoryloxy)methyl, and 8-carbamates derivatives thereof substituted at the 5-position are described as useful for iron chelation and neuroprotective therapies.. .
Varinel Inc.
01/22/15
20150024047

Pharmaceutical composition and administrations thereof


The present invention relates to pharmaceutical compositions containing a solid dispersion of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.. .
Vertex Pharmaceuticals Incorporated
01/22/15
20150023990

Alkoxy substituted imidazoquinolines


Imidazoquinoline compounds with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral, and neoplastic, are disclosed.. .
3m Innovative Properties Company
01/22/15
20150023930

Aminoquinoline derivatives and uses thereof


Described herein are aminoquinoline and aminoacridine based hybrids, pharmaceutical compositions and medicaments that include such aminoquinoline and aminoacridine based hybrids, and methods of using such compounds for diagnosing and/or treating infections, neurodegerative diseases or disorders, inflammation, inflammation associated diseases and disorders, and/or diseases or disorders that are treatable with dopamine agonists such as the restless leg syndrome.. .
The Mclean Hospital Corporation
01/08/15
20150011770

Group 4 metal compound containing thiophene-fused cyclopentadienyl ligand derived from tetraquinoline derivative and olefin polymerization using the same


The present invention relates to a novel ligand derived from a tetrahydroquinoline derivative, and a transition metal compound prepared using the ligand, where an amido ligand is linked to an ortho-phenylene ligand to form a condensed ring and a 5-membered cyclic pi-ligand linked to the ortho-phenylene ligand is fused with a heterocyclic thiophene ligand. Compared with the catalysts not fused with a heterocyclic thiophene ligand, the transition metal compound of the present invention as activated with a co-catalyst has higher catalytic activity in olefin polymerization and provides a polymer with higher molecular weight..
Lotte Chemical Corporation
01/08/15
20150010628

Pharmaceutical composition and administrations thereof


The present invention relates to pharmaceutical compositions containing a solid dispersion of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders and mini-tablets and methods for treating cystic fibrosis employing the pharmaceutical composition.. .
Vertex Pharmaceuticals Incorporated
01/01/15
20150004231

Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2


The present invention relates to new pharmaceutical compositions comprising benzoquinoline compounds, and methods to inhibit vesicular monoamine transporter 2 (vmat2) activity in a subject for the treatment of chronic hyperkinetic movement disorders.. .
Auspex Pharmaceuticals, Inc.
01/01/15
20150000691

Coupler with 7-amino-1,2,3,4-tetrahydroquinoline structure, dyeing composition comprising same, processes and uses


The invention relates to the use of specific heterocyclic couplers which are 7-amino-1,2,3,4-tetrahydroquinoline derivatives of formula (i) for dyeing keratin fibres such as the hair in which formula (i): r1 to r6, ra to rc and x are as defined in the description.. .
L'oreal
12/25/14
20140378718

Method for reducing acids in crude oil


Introducing an additive into a crude oil may result in the crude oil having comparatively lower acid levels as compared to an otherwise identical crude oil absent the additive. The additive may include nanoparticles of metal oxides, oil soluble hydrogen donors, and/or heavy amines.
Baker Hughes Incorporated
12/25/14
20140378711

Method for synthesizing 2,7-dimethyl-2,4,6-octatriene-1,8-dialdehyde


Provided in the present invention is a method for synthesizing 2,7-dimethyl-2,4,6-octatriene-1,8-dialdehyde. The synthesis method comprises the following steps: (1) adding acetaldehyde diethyl acetal and ethyl-(1-propenyl)-ether under the effect of a catalyst to produce 1,1,3-triethoxy-2-methyl-butane; (2) pyrolysis synthesizing 1,1,3-triethoxy-2-methyl-butane under the catalytic effects of isoquinoline and p-toluenesulfonic acid to produce 1-methoxy-2-methyl-1,3-butadiene; (3) dissolving 1-methoxy-2-methyl-1,3-butadiene in anhydrous ethanol solvent for synthesis with a phase transfer catalyst, cetyl-trimethyl ammonium bromide, and a chlorinating agent, trichloroisocyanuric acid, to generate 4,4-diethoxy-3-methyl-1-chloro-butene; (4) combining 4,4-diethoxy-3-methyl-1-chloro-butene with a triphenylphosphine salt to produce a phosphonium salt; and (5) condensing the phosphonium salt under the effects of hydrogen peroxide in conjunction with sodium carbonate solution to generate 1,1,8,8-tetramethyl-2,7-dimethyl-2,4,6-octatriene; then hydrolyzing under acidic conditions to synthesize 2,7-dimethyl-2,4,6-octatriene-1,8-dialdehyde.
Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory
12/25/14
20140378441

Therapeutic agent for ocular fundus disease


Disclosed herein is a prophylactic or therapeutic agent for ocular fundus disease, especially diabetic retinopathy or age-related macular degeneration. The prophylactic or therapeutic agent for ocular fundus disease comprising: (s)-(−)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine, a salt thereof, or a solvate thereof, as an active ingredient..
Kowa Company, Ltd.
12/25/14
20140377783

Novel applications of indoloindole and indoloquinoline dyes


A novel type of dye systems comprises a selection of 10h-indolo[1,2-a]indole compounds (henceforth abbreviated as io compounds) and (5h,7h)-indolo[1,2-a]quinoline compounds (henceforth abbreviated as iq compounds) showing a solvatochromic effect and exhibiting strong fluorescence in a variety of materials such as polypropylene, polyethylene, oils, various solvents, emulsions. Also disclosed are various methods how the io/iq compounds can be administered, especially how they can be produced and administered in situ from a precursor, responding to external stimuli such as enzyme activity, temperature and so forth.
12/25/14
20140373989

Tire


The present invention aims to provide a tire having improved abrasion resistance and appearance, as well as reduced rolling resistance and therefore improved fuel economy. The present invention relates to a tire including a tread, the tread containing 0.9 to 1.5% by mass of a wax, 0.9 to 1.5% by mass of an amine antioxidant, 0.3 to 1.0% by mass of a quinoline antioxidant, and a tread rubber component containing 3% by mass or more of a polybutadiene rubber, the tread having a rubber thickness between a tread groove bottom and an outermost belt-reinforcing layer of 0.1 to 2.0 mm..
Sumitomo Rubber Industries, Ltd.
12/25/14
20140373286

Oxidative dyeing composition


Present invention relates to an aqueous oxidizing composition with improved stability. The object of the present invention is an aqueous composition comprising at least one oxidizing agent, salicylic acid and/or its salts and either acetaminophen or oxyquinoline and/or its salts and having a ph between 1 and 5..
Kao Germany Gmbh
12/18/14
20140371459

Industrial process for preparation of 1,2-dihydroquinoline derivative or a salt thereof, and intermediate for preparation thereof


Or a salt thereof in the presence of a base. The method is a method for producing a 1,2-dihydroquinoline derivative having glucocorticoid receptor binding activity or a salt thereof.
12/18/14
20140371259

Compounds and methods for inhibition of ap endonuclease-1/redox factor-1 (hape1) activity


A method for treating a neoplasm in a subject, comprising co-administering to the subject a therapeutically effective amount of an anticancer agent and a substituted 6,7-methylenedioxy-4-amino-quinoline, or a pharmaceutically acceptable salt or ester thereof.. .
University Of Pittsburgh - Of The Commonwealth System Of Higher Education
12/18/14
20140371221

Quinoline compound composing 1,2,4-triazine-dione and use thereof


The present invention relates to a quinoline derivative represented by general formula (i) or a pharmaceutically acceptable salt, hydrate, solvate or prodrug thereof wherein ar, r1, r2, r3, x, y and n have the meanings given in the description. The present invention also relates to the comparatively strong effect of the compound represented by general formula (i) on inhibiting c-met kinase.
Wuhan Shengyun Biopharma Co., Ltd.
12/11/14
20140364613

Compounds of 3-(5-sustituted oxy-2, 4-dinitrophenyl)-2-oxo-propionic acid ester, synthesis and applications thereof


Synthesis of the novel compound 3 (3-(5-substituted oxy-2,4-dinitro-phenyl)-2-oxo-propionic acid ester) to make pyrroloquinoline quinone (pqq) and using it for pharmaceutical purposes is described. More specifically, this disclosure relates to synthesizing the pqq in an efficient method by using a novel intermediate formula 1 resulting in a shorter process and higher yield of pqq.
12/11/14
20140364454

Metal-chelating compounds having at least one polyamino chain


The invention relates to metal-chelating compounds comprising one or more 8-hydroxyquinoline units substituted in position 2 with a nitrogenous group comprising a polyamino chain, wherein the polyamino chain is n-substituted on said nitrogenous group, to the composition containing same, and to the uses thereof in the therapeutic field and in particular in the treatment of diseases associated with an abnormality in the regulation of metal metabolism resulting in a metal overload in human or animal cells.. .
12/11/14
20140364441

Crystalline forms of (s)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof


Novel [1,2,4]triazolo[1,5-a]pyridinyl-6-yl-substituted tetrahydroisoquinolines are described in the present invention. These compounds and crystalline forms sa1 and n-2 are used in the treatment of various neurological and physiological disorders.
12/11/14
20140364431

Quinoline and cinnoline derivatives and their applications


The present invention relates to a series of quinoline and cinnoline derivatives of general formula i, pharmaceutically acceptable salts, hydrates, solvates or prodrugs thereof. And the compounds of general formula i show potent inhibitory activity gainst c-met kinase.
12/11/14
20140364424

Novel sulfonaminoquinoline hepcidin antagonists


The present invention relates to novel hepcidin antagonists, pharmaceutical compositions comprising them and the use thereof as medicaments for the use in the treatment of iron metabolism disorders, such as, in particular, iron deficiency diseases and anemias, in particular anemias in connection with chronic inflammatory diseases.. .
12/11/14
20140364389

Combination therapy


The present invention relates to a combination therapy for treating an hiv infection or inhibiting integrase comprising (s)-6-(3-chloro-2-fluorobenzyl)-1-(1-hydroxymethyl-2-methylpropyl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (“compound a”) or a pharmaceutically acceptable solvate or salt thereof in combination with at least one other anti-hiv agent. In some embodiments of the present invention, the other anti-hiv agents are chosen from reverse transcriptase inhibitors and protease inhibitors.
12/11/14
20140361252

Aluminum chelates as materials for oleds


Aluminum chelate complex compounds with two substituted 8-hydroxyquinoline ligand and one dibenzothiophene, dibenzofuran or dibenzoselenophene ligands or aza-analogs of these molecules, attached directly or through an aromatic spacer to the oxygen atom is provided to improve lifetime, operating voltage and efficiency of an oled. Additional substitution of dibenzothiophene or dibenzofuran ring may also provide charge delocalization, homo modification and higher tg..
12/04/14
20140357768

Color-stable thermoplastic composition


Wherein z1 represents the atoms necessary to complete a 9- to 13-membered single or fused aromatic ring structure, z2 represents the atoms necessary to complete a pyridine or quinoline ring, each r1 and each r2 can independently be halogen, an alkyl group, an aryl group, a heterocyclic group, an alkoxy group, an aryloxy group, an aromatic or aliphatic thioether group, an aromatic or aliphatic carboxylic acid ester group, or an aromatic or aliphatic amide group, a is an integer from 0 to 6, b is an integer from 0 to 4, n is 1 or 2, and x is present only if n=2 and is a single bond or a divalent organic radical bonded to the z1 ring structure through an ether, ketone, or thio linkage.. .
12/04/14
20140356873

Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings


The present invention describes novel dyes, including coumarins, rhodamines, and rhodols that incorporate additional fused aromatic rings. The dyes of the invention absorb at a longer wavelength than structurally similar dyes that do not possess the fused aromatic rings.
12/04/14
20140352713

Coupler with cationic 7-amino-1,2,3,4-tetrahydroquinoline structure, dyeing composition comprising same, processes and uses


The invention relates to the use of specific heterocyclic couplers which are cationic 7-amino-1,2,3,4-tetrahydroquinoline derivatives of formula (i) for dyeing keratin fibres such as the hair: in which formula (i): r1 to r6, cat+, an−, and ra to rb are as defined in the description.. .
11/27/14
20140350264

Process for the preparation of (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid esters


The invention relates to a process for the preparation of a compound of formula (i) wherein r1 is c1c6 alkyl or benzyl by reacting a compound of formula (ii) wherein r1 is as defined for formula (i) with 2-quinoline carboxaldehyde. The process is suitable for use on an industrial scale..
11/27/14
20140350048

Compounds, compositions and associated methods comprising 3-aryl quinolines


Compounds, compositions and methods useful for treating infectious diseases are provided. In particular, 3-aryl quinoline compounds, their synthesis, pharmaceutical compositions thereof and methods of treating infectious diseases such as malaria, are disclosed..
11/27/14
20140350044

Benzoquinoline inhibitors of vesicular monoamine transporter 2


The present invention relates to new benzoquinoline inhibitors of vesicular monoamine transporter 2 (vmat2), pharmaceutical compositions thereof, and methods of use thereof.. .


Popular terms: [SEARCH]

Quinoline topics: Isoquinolin, Praziquantel, Carbon Atoms, Crystallin, Quinoline Derivatives, Pharmaceutically Acceptable Salt, Alkyl Group, Cycloalkyl, Pharmaceutically Acceptable Salts, Immunodeficiency, Retrovirus, Viral Infection, Human Immunodeficiency Virus, Angiogenesis, Sulfonamide

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Quinoline for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Quinoline with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         









0.9027

3460

459075 - 0 - 72